Dual-Agent Eye Drop for Presbyopia - Scorecard - MDSpire

Dual-Agent Eye Drop for Presbyopia

YUVEZZI™ approved for the treatment of presbyopia, blurry close-up vision due to aging

  • April 20, 2026

  • 2 min

Share

Clinical Scorecard: Dual-Agent Eye Drop for Presbyopia

At a Glance

CategoryDetail
ConditionPresbyopia
Key MechanismsCombination of carbachol and brimonidine tartrate to improve near vision.
Target PopulationAdults experiencing presbyopia, typically starting around age 45.
Care SettingPrescribed by eye care professionals, available through e-pharmacy and retail pharmacies.

Key Highlights

  • YUVEZZI is the first dual-agent eye drop approved for presbyopia.
  • Single drop, once-daily dosing improves near vision.
  • Designed to meet the real-world needs of aging adults.

Guideline-Based Recommendations

Diagnosis

  • Diagnosis of presbyopia typically occurs in adults around age 45.

Management

  • Prescribe YUVEZZI for improved near vision in adults with presbyopia.

Monitoring & Follow-up

  • Monitor patient response to treatment and adjust as necessary.

Risks

  • Evaluate for potential side effects associated with carbachol and brimonidine tartrate.

Patient & Prescribing Data

Adults with presbyopia.

YUVEZZI offers a convenient treatment option that reduces reliance on reading glasses.

Clinical Best Practices

  • Educate patients on the proper use of YUVEZZI.
  • Assess the patient's vision needs and lifestyle when prescribing.

Related Resources & Content

Original Source(s)

Dual-Agent Eye Drop for Presbyopia

  • April 20, 2026

Related Content

Therapeutic Focus: <em>Drop</em>ping Some Knowledge

Vizz (aceclidine ophthalmic solution) 1.44%, from Lenz Therapeutics, offers spectacle-free vision and the opportunity to secure patient loyalty.

The Evolution of Treatments for Emmetropic Presbyopia

Often, these patients are unhappy with this reality check of aging and do not want to wear reading glasses, which is why practitioners and industry are always looking for ways to help. The challenge is to develop therapies that correct presbyopia while maintaining the emmetrope’s clear distance vision.

Women Prefer Contact Lens Under-Correction

Clinic-based study suggests sex differences in preferred contact lens under-correction during presbyopia management